People wait to receive Pfizer/BioNTech COVID-19 vaccine at a vaccination centre temporarily set up in a trade fair hall amid the coronavirus disease pandemic in Cologne, Germany March 18, 2021. REUTERS/Thilo Schmuelgen
BERLIN (Reuters) - The founder of BioNTech, partner with Pfizer in making one of the first coronavirus vaccines to be approved for use, is optimistic that the virus will be under control in most European countries by the end of the summer despite a faltering vaccine roll-out.
In Germany, owners of shuttered shops and would-be holidaymakers are increasingly restive over COVID-19 restrictions. Some 20,000 people protested against lockdown in the central city of Kassel on Saturday.
